Liposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric Cancer
Liposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric Cancer
Active, not recruiting · NCT03764553 · Registry updated 2026-08-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Liposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric Cancer | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, esophageal cancer, esophageal disorder, neoplasm | Active, not recruiting | Phase 2 | 2026-08-21 | NCT03764553 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 199 |
| Servier | 21 |
34 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.